Renalytix Plc
RENXF
$0.02
-$0.01-35.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.05M | -4.05M | -3.87M | -7.74M | -8.49M |
| Total Depreciation and Amortization | -- | -- | -60.00K | 69.00K | 108.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 650.00K | 650.00K | 382.00K | 2.08M | 470.00K |
| Change in Net Operating Assets | 700.00K | 700.00K | -2.91M | 734.00K | -12.00K |
| Cash from Operations | -2.70M | -2.70M | -6.46M | -4.86M | -7.92M |
| Capital Expenditure | -50.00K | -50.00K | -- | -3.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.00K | -50.00K | -- | -3.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.10M | -2.10M | -3.50M | 0.00 | -600.00K |
| Issuance of Common Stock | 6.40M | 6.40M | 18.48M | 5.07M | 93.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1.04M | 0.00 |
| Cash from Financing | 4.30M | 4.30M | 14.98M | 4.03M | -507.00K |
| Foreign Exchange rate Adjustments | -300.00K | -300.00K | -242.00K | -83.00K | 154.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.25M | 1.25M | 8.27M | -915.00K | -8.27M |